Sai Life Sciences Limited (NSE:SAILIFE)
1,585.00
-6.10 (-0.38%)
Sep 11, 2026, 3:29 PM IST
Sai Life Sciences Revenue
Sai Life Sciences had revenue of 5.54B INR in the quarter ending June 30, 2026, with 11.66% growth. This brings the company's revenue in the last twelve months to 22.50B, up 17.74% year-over-year. In the fiscal year ending March 31, 2026, Sai Life Sciences had annual revenue of 21.92B with 29.38% growth.
Revenue (ttm)
22.50B
Revenue Growth
+17.74%
P/S Ratio
14.94
Revenue / Employee
4.31M
Employees
5,224
Market Cap
336.20B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 21.92B | 4.98B | 29.38% |
| Mar 31, 2025 | 16.95B | 2.29B | 15.66% |
| Mar 31, 2024 | 14.65B | 2.48B | 20.38% |
| Mar 31, 2023 | 12.17B | 3.48B | 39.97% |
| Mar 31, 2022 | 8.70B | 1.10B | 14.44% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 599.11B |
| Apollo Hospitals Enterprise | 264.30B |
| Divi's Laboratories | 112.30B |
| Emcure Pharmaceuticals | 96.83B |
| Lenskart Solutions | 96.34B |
| Narayana Hrudayalaya | 90.72B |
| Krishna Institute of Medical Sciences | 42.13B |
| Wockhardt | 36.53B |
Sai Life Sciences News
- 5 weeks ago - Sai Life Sciences Transcript: Q1 26/27 - Transcripts
- 5 weeks ago - Sai Life Sciences Quarterly report: Q1 2027 - Filings
- 5 weeks ago - Sai Life Sciences Slides: Q1 2027 - Filings
- 3 months ago - Sai Life Sciences Transcript: Q4 25/26 - Transcripts
- 3 months ago - Sai Life Sciences Quarterly report: Q4 2026 - Filings
- 3 months ago - Sai Life Sciences Slides: Q4 2026 - Filings
- 3 months ago - Sai Life Sciences Annual report: Q4 2026 - Filings
- 7 months ago - Sai Life Sciences Transcript: Q3 25/26 - Transcripts